Fibrinopeptide A and sudden coronary death

Area of Science:

• Cardiology
• Biochemistry
• Pathophysiology

Background:

• Ischaemic heart disease (IHD) is a leading cause of sudden cardiac death.
• The role of acute thrombosis in sudden IHD death requires further elucidation.
• Fibrinopeptide A (FPA) is a marker of thrombin generation.

Purpose of the Study:

• To investigate Fibrinopeptide A (FPA) concentrations in sudden cardiac death due to IHD.
• To compare FPA levels between IHD and non-IHD sudden death cases.
• To explore the association between FPA levels and a history of IHD.

Main Methods:

• Blood samples were collected via direct cardiac puncture from deceased individuals.
• Fibrinopeptide A (FPA) concentrations were measured.
• Patients were categorized into sudden death from IHD and sudden death from other causes.

Main Results:

• Mean FPA concentration was five times higher in the IHD group compared to the non-IHD group.
• Elevated FPA levels were predominantly observed in IHD patients with a documented history of the disease.
• Differences in resuscitation methods were unlikely to explain the observed FPA variations.

Conclusions:

• Increased thrombin generation, indicated by high FPA, may be implicated in the pathophysiology of sudden IHD death.
• This association appears particularly strong in patients with a prior history of IHD.
• Findings suggest thrombin production could precipitate or exacerbate events leading to sudden IHD mortality.